TABLE 2.
Univariate Cox regression of risk factors for MACE.
| Character | HR (95% CI) | P-value | |
| Cardiovascular risk factors | |||
| Gender (1 = male, 2 = female) | 0.83 | (0.55–1.27) | 0.40 |
| Age (years) | 1.07 | (1.04–1.11) | <0.01* |
| Family history of premature CVD (1 = yes, 2 = no) | 1.15 | (0.70–1.89) | 0.59 |
| Smoking, n (%) | 1.29 | (0.74–2.25) | 0.36 |
| TC (mmol/L) | 0.97 | (0.79–1.20) | 0.78 |
| TG (mmol/L) | 1.02 | (0.83–1.26) | 0.85 |
| HDLC (mmol/L) | 0.73 | (0.40–1.33) | 0.30 |
| LDLC (mmol/L) | 0.98 | (0.77–1.25) | 0.87 |
| SBP (mmHg) | 0.99 | (0.98–1.00) | 0.21 |
| DBP (mmHg) | 0.98 | (0.96–1.01) | 0.15 |
| eGFR (ml/min/1.73 m2) | 0.98 | (0.97–0.99) | <0.01* |
| Anthropometric character | |||
| Height (cm) | 0.97 | (0.95–1.00) | 0.04* |
| Weight (Kg) | 0.99 | (0.97–1.01) | 0.16 |
| Waist circumference (cm) | 0.99 | (0.97–1.02) | 0.56 |
| Hip circumference (cm) | 0.99 | (0.96–1.02) | 0.60 |
| MUAC (cm) | 0.89 | (0.82–0.96) | <0.01* |
| BMI (kg/m2) | 1.00 | (0.94–1.06) | 0.97 |
| WHR | 0.55 | (0.02–14.64) | 0.72 |
| Obesity (1 = yes, 2 = no) | 0.75 | (0.39–1.44) | 0.38 |
| Central obesity (1 = yes, 2 = no) | 1.09 | (0.70–1.69) | 0.70 |
| Diseases | |||
| DM (1 = yes, 2 = no) | 1.99 | (1.30–3.07) | <0.01* |
| Hypertension (1 = yes, 2 = no) | 1.15 | (0.74–1.78) | 0.54 |
| Hyperlipidemia (1 = yes, 2 = no) | 0.86 | (0.56–1.32) | 0.49 |
| Stroke history (1 = yes, 2 = no) | 1.98 | (1.27–3.08) | <0.01* |
| CHD history (1 = yes, 2 = no) | 1.82 | (1.20–2.75) | 0.01* |
Association of MACE with all risk factors was analyzed by univariate Cox regression.
*P-values < 0.05 are considered significant.
CVD, cardiovascular disease; TC, triglyceride; TG, total cholesterol; HDLC, high density lipoprotein cholesterol; LDLC, low density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; MUAD, middle-up arm circumference; BMI, body mass index; WHR, waist-to-hip ratio; DM, diabetes mellitus; CHD, coronary heart disease.